{"id":{"repo_id":"vilnius","oai_identifier":"oai:vu.lt:elaba:192829674"},"canonical_url":"https://search.ndltd.org/etd/vilnius/oai:vu.lt:elaba:192829674","repository":{"repo_id":"vilnius","name":"Vilnius University","base_url":"https://epublications.vu.lt/oai"},"display":{"title":"Impact of colorectal cancer screening program on mortality in lithuania /","abstract":"INTRODUCTION: Lithuania's colorectal cancer (CRC) screening program originated in June 2009 and from January 2014 onwards, the program covers a population aged between 50 to 74. CRC screening program is based on reducing the incidence and mortality by removal of advanced adenoma and the early detection of the disease. AIM: To assess the impact of colorectal cancer screening on the mortality rates in Lithuania METHODS: This study consists of a retrospective review of prospectively maintained data extracted from the National Colorectal Cancer Screening database of all individuals aged 50-74 who participated in the national colorectal screening program between the years 2013-2019 in Lithuania. The data on survival was extracted from the same database. We performed statistical data analysis using R statistical software package V 4.2.2 (2022-10-31) (© 2022 The R Foundation for Statistical Computing), RStudio 2022.07.2 Build 576 © 2009–2022 RStudio, PBC. RESULTS: 4% of individuals, who tested negative on the fecal immunochemical test (FIT) died, as compared to 5% of FIT-positive patients, who either had a normal colonoscopy or had adenoma, polyp, or normal tissues on colonoscopy biopsy; 8 % of patients, who had high-grade dysplasia died as well as 19% of those, that had biopsy-proven CRC. The mortality risk in FIT-positive individuals who did not undergo screening colonoscopy was significantly (78%) higher than in those, who completed their colonoscopy (9% vs 5%). Overall, completing FIT screening is associated with a reduced risk of death over 5 years. CONCLUSIONS: There is a strong correlation between the results of CRC screening results and the overall risk of death over the period of 5 years. Completing CRC screening in FIT-positive patients is associated with a 78 % reduction in the risk of death.","abstract_html":"INTRODUCTION: Lithuania&#x27;s colorectal cancer (CRC) screening program originated in June 2009 and from January 2014 onwards, the program covers a population aged between 50 to 74. CRC screening program is based on reducing the incidence and mortality by removal of advanced adenoma and the early detection of the disease. AIM: To assess the impact of colorectal cancer screening on the mortality rates in Lithuania METHODS: This study consists of a retrospective review of prospectively maintained data extracted from the National Colorectal Cancer Screening database of all individuals aged 50-74 who participated in the national colorectal screening program between the years 2013-2019 in Lithuania. The data on survival was extracted from the same database. We performed statistical data analysis using R statistical software package V 4.2.2 (2022-10-31) (© 2022 The R Foundation for Statistical Computing), RStudio 2022.07.2 Build 576 © 2009–2022 RStudio, PBC. RESULTS: 4% of individuals, who tested negative on the fecal immunochemical test (FIT) died, as compared to 5% of FIT-positive patients, who either had a normal colonoscopy or had adenoma, polyp, or normal tissues on colonoscopy biopsy; 8 % of patients, who had high-grade dysplasia died as well as 19% of those, that had biopsy-proven CRC. The mortality risk in FIT-positive individuals who did not undergo screening colonoscopy was significantly (78%) higher than in those, who completed their colonoscopy (9% vs 5%). Overall, completing FIT screening is associated with a reduced risk of death over 5 years. CONCLUSIONS: There is a strong correlation between the results of CRC screening results and the overall risk of death over the period of 5 years. Completing CRC screening in FIT-positive patients is associated with a 78 % reduction in the risk of death.","abstract_has_math":false,"creators":["Thattakath, Cassini William,"],"institution":"Institutional Repository of Vilnius University","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2023,"date_issued":"2023","date_published":"2023","updated_at":"2026-11-19T09:55:35Z","subjects":["Colorectal cancer, Screening, Fecal immunochemical test, Colonoscopy, Mortality"],"languages":["eng"],"rights":["info:eu-repo/semantics/openAccess"],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://repository.vu.lt/VU:ELABAETD192829674&prefLang=en_US","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://repository.vu.lt/VU:ELABAETD192829674&prefLang=en_US","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":"open","embargo_until":null,"access_note":null},"source_record":{"url":"https://epublications.vu.lt/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Avu.lt%3Aelaba%3A192829674","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Thattakath, Cassini William,"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2023"]},{"key":"dc:publisher","label":"Institution","values":["Institutional Repository of Vilnius University"]},{"key":"dc:relation","label":"Dc Relation","values":["https://epublications.vu.lt/object/elaba:192829674/192829674.pdf"]},{"key":"dc:type","label":"Dc Type","values":["info:eu-repo/semantics/masterThesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Colorectal cancer, Screening, Fecal immunochemical test, Colonoscopy, Mortality"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["info:eu-repo/semantics/openAccess"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://repository.vu.lt/VU:ELABAETD192829674&prefLang=en_US"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["INTRODUCTION: Lithuania's colorectal cancer (CRC) screening program originated in June 2009 and from January 2014 onwards, the program covers a population aged between 50 to 74. CRC screening program is based on reducing the incidence and mortality by removal of advanced adenoma and the early detection of the disease. AIM: To assess the impact of colorectal cancer screening on the mortality rates in Lithuania METHODS: This study consists of a retrospective review of prospectively maintained data extracted from the National Colorectal Cancer Screening database of all individuals aged 50-74 who participated in the national colorectal screening program between the years 2013-2019 in Lithuania. The data on survival was extracted from the same database. We performed statistical data analysis using R statistical software package V 4.2.2 (2022-10-31) (© 2022 The R Foundation for Statistical Computing), RStudio 2022.07.2 Build 576 © 2009–2022 RStudio, PBC. RESULTS: 4% of individuals, who tested negative on the fecal immunochemical test (FIT) died, as compared to 5% of FIT-positive patients, who either had a normal colonoscopy or had adenoma, polyp, or normal tissues on colonoscopy biopsy; 8 % of patients, who had high-grade dysplasia died as well as 19% of those, that had biopsy-proven CRC. The mortality risk in FIT-positive individuals who did not undergo screening colonoscopy was significantly (78%) higher than in those, who completed their colonoscopy (9% vs 5%). Overall, completing FIT screening is associated with a reduced risk of death over 5 years. CONCLUSIONS: There is a strong correlation between the results of CRC screening results and the overall risk of death over the period of 5 years. Completing CRC screening in FIT-positive patients is associated with a 78 % reduction in the risk of death."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["Impact of colorectal cancer screening program on mortality in lithuania /","Impact of Colorectal Cancer Screening Program on Mortality in Lithuania."]}]}],"canonical_facts":{"dc:creator":["Thattakath, Cassini William,"],"dc:date":["2023"],"dc:description":["INTRODUCTION: Lithuania's colorectal cancer (CRC) screening program originated in June 2009 and from January 2014 onwards, the program covers a population aged between 50 to 74. CRC screening program is based on reducing the incidence and mortality by removal of advanced adenoma and the early detection of the disease. AIM: To assess the impact of colorectal cancer screening on the mortality rates in Lithuania METHODS: This study consists of a retrospective review of prospectively maintained data extracted from the National Colorectal Cancer Screening database of all individuals aged 50-74 who participated in the national colorectal screening program between the years 2013-2019 in Lithuania. The data on survival was extracted from the same database. We performed statistical data analysis using R statistical software package V 4.2.2 (2022-10-31) (© 2022 The R Foundation for Statistical Computing), RStudio 2022.07.2 Build 576 © 2009–2022 RStudio, PBC. RESULTS: 4% of individuals, who tested negative on the fecal immunochemical test (FIT) died, as compared to 5% of FIT-positive patients, who either had a normal colonoscopy or had adenoma, polyp, or normal tissues on colonoscopy biopsy; 8 % of patients, who had high-grade dysplasia died as well as 19% of those, that had biopsy-proven CRC. The mortality risk in FIT-positive individuals who did not undergo screening colonoscopy was significantly (78%) higher than in those, who completed their colonoscopy (9% vs 5%). Overall, completing FIT screening is associated with a reduced risk of death over 5 years. CONCLUSIONS: There is a strong correlation between the results of CRC screening results and the overall risk of death over the period of 5 years. Completing CRC screening in FIT-positive patients is associated with a 78 % reduction in the risk of death."],"dc:format":["application/pdf"],"dc:identifier":["https://repository.vu.lt/VU:ELABAETD192829674&prefLang=en_US"],"dc:language":["eng"],"dc:publisher":["Institutional Repository of Vilnius University"],"dc:relation":["https://epublications.vu.lt/object/elaba:192829674/192829674.pdf"],"dc:rights":["info:eu-repo/semantics/openAccess"],"dc:subject":["Colorectal cancer, Screening, Fecal immunochemical test, Colonoscopy, Mortality"],"dc:title":["Impact of colorectal cancer screening program on mortality in lithuania /","Impact of Colorectal Cancer Screening Program on Mortality in Lithuania."],"dc:type":["info:eu-repo/semantics/masterThesis"]},"updated_at":"2026-11-19T09:55:35Z"}